Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
酸化CMマンノグルカン-ドキソルビシン複合体の抗腫瘍効果および毒性・副作用
加治木 正洋矢野 敏朗権正 晃徳川口 隆行奥野 哲井上 和泓
著者情報
ジャーナル フリー

1993 年 8 巻 4 号 p. 263-267

詳細
抄録
Oxidized carboxymethyl-D-manno-n-glucan-DXR conjugates (MG-CM-AD-DXR) prepared via Schiff's base formation possesses not only higher concentration in plasma and tumor but also lower in heart than DXR. In the present investigation, antitumor effects and toxicities of the conjugates were compared with those of DXR. MG-CM [0.5]-AD-DXR (DS of CM groups : 0.5) and MG-CM [1.0] -AD-DXR (DS of CM groups : 1.0)exhibited a growth inhibition similar to DXR against mouse leukemia P388 cells in vitro, but were found to be 2.3-and 1.7-fold more potent than DXR after the intravenous injection in rats bearing Walker 256, respectively. MG-CM[0.5]-AD-DXR conjugate also showed 1.7-fold more effective than DXR in rats bearing Yoshida sar coma. On the other hand, toxicities of MG-CM[0.5]-AD-DXR in rats, reduction of peripheral white blood cells and platelets counts on day 4 and body weight loss, were less than those of DXR after the intravenous injection at a dose of 10 mg/kg as DXR. These toxicities induced by MG-CM[1.0]-AD-DXR were similar to those by DXR, and MG-CM[0.5]-AD-DXR conjugate had less lethal toxicity than DXR in mice.
著者関連情報
© 日本DDS学会
前の記事 次の記事
feedback
Top